Gainers & Losers
Thu Nov 28 2024 10:27:13
  1. State Bank Of India share price
  2. 838.750.55%
Mutual Fund Ownership
Ownership as on: Fri, 29 Nov, 2024

ICICI Prudential Nifty Pharma Index Fund Regular Growth

NA
Index Funds
Amount Invested (Cr.)7.45
% of AUM9.43%

Nippon India Pharma Fund - Growth

NA
Equity
Amount Invested (Cr.)795.58
% of AUM9.16%

HDFC Pharma and Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)109.32
% of AUM7.91%

Baroda BNP Paribas Manufacturing Fund Regular Growth

NA
Equity
Amount Invested (Cr.)106.02
% of AUM7.42%

SBI Healthcare Opportunities Fund Regular Growth

NA
Equity
Amount Invested (Cr.)212.03
% of AUM6.21%

FAQs about Divis Laboratories share price

Divis Laboratories is trading at 5977.95 as on Thu Nov 28 2024 09:59:58. This is -0.38% lower as compared to its previous closing price of 6000.95.

The market capitalization of Divis Laboratories is 159259.90 Cr as on Thu Nov 28 2024 09:59:58.

The average broker rating on Divis Laboratories is Hold. The breakup of analyst rating is given below -

  • 3 analysts have given a strong buy rating
  • 4 analysts have given a buy rating
  • 5 analysts have given a hold rating
  • 5 analysts have given a sell rating
  • 6 analysts have given a strong sell rating

The 52 wk high for Divis Laboratories is 6276.20 whereas the 52 wk low is 3350.05

Divis Laboratories can be analyzed on the following key metrics -

  • TTM P/E: 78.73
  • Sector P/E: 39.95
  • Dividend Yield: 0.50%
  • D/E ratio: 0.00

Divis Laboratories reported a net profit of 1600.00 Cr in 2024.

Recommended For You
Trending Stocks
1,857.45-66.65 (-3.46%)
2,903.35-101.00 (-3.36%)
HomeMarketsPremiumInstant LoanMint Shorts